[Ni 2 (3,5-bis( N -methylimidazolylidenylmethyl)pyrazolate) 2 ](PF 6 ) 2 ( 1 ), [Ni 2 (μ-OH)(3,5-bis( N -pycolylimidazolylidenylmethyl)pyrazolate)](PF 6 ) 2 ( 2 ), and [Ni 2 (μ-OH)(3,5-bis( N -pyridylimidazolylidenylmethyl)pyrazolate)](PF 6 ) 2 ( 3 ) have been prepared from the corresponding imidazolium salts via in situ generated silver-carbene complexes. The complexes and imidazolium salts were characterized by elemental analyses and NMR spectroscopy. The structures of 1 − 3 were identified by X-ray diffraction analysis. In complex 1, two nickel(II) ions are sandwiched by two 3,5-bis( N -methylimidazolylidenylmethyl)pyrazolates behaving as anionic tetradentate ligands. Complexes 2 and 3 contain Ni 2 (μ-OH) cores with two nickel centers bridged by anionic hexadentate imidazolylidene ligands. Complexes 2 and 3 show excellent catalytic activities in Suzuki−Miyaura and Kumada−Corriu coupling reactions of various aryl chlorides. The cross-coupling reactions of deactivated aryl chlorides with arylboronic acids and Grignard reagents have been accomplished in excellent yields at low catalyst loadings.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: